← Back to Search

Medical Food

Enteral Tube-fed Adults for Tube Feeding

N/A
Waitlist Available
Research Sponsored by Nestlé
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial will study a new, high protein enteral formula to see if it meets nutrition goals for patients who cannot eat by mouth.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Calorie nutritional goals
Secondary outcome measures
Adverse events
Daily reports of gastrointestinal intolerance
Protein nutritional goals

Trial Design

1Treatment groups
Experimental Treatment
Group I: Enteral Tube-fed AdultsExperimental Treatment1 Intervention
Adults being fed an enteral formula with a feeding tube

Find a Location

Who is running the clinical trial?

NestléLead Sponsor
321 Previous Clinical Trials
60,683 Total Patients Enrolled
2 Trials studying Tube Feeding
50 Patients Enrolled for Tube Feeding
Société des Produits Nestlé (SPN)Lead Sponsor
337 Previous Clinical Trials
62,536 Total Patients Enrolled
2 Trials studying Tube Feeding
50 Patients Enrolled for Tube Feeding
Krysmaru Araujo Torres, MDStudy DirectorNestle Health Science
3 Previous Clinical Trials
46 Total Patients Enrolled

Media Library

Peptide-Based Enteral Formula (Medical Food) Clinical Trial Eligibility Overview. Trial Name: NCT05025267 — N/A
Tube Feeding Research Study Groups: Enteral Tube-fed Adults
Tube Feeding Clinical Trial 2023: Peptide-Based Enteral Formula Highlights & Side Effects. Trial Name: NCT05025267 — N/A
Peptide-Based Enteral Formula (Medical Food) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05025267 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025